摘要
晚期肝内胆管细胞癌是仅次于肝细胞肝癌的常见肝脏恶性肿瘤,其发病隐匿,治疗手段有限,预后较差。晚期不可切除肝内胆管细胞癌的推荐治疗方案为系统性治疗。笔者报道1例肝内胆管细胞癌病人行肝动脉化疗栓塞联合免疫靶向治疗的临床经验,其研究结果显示:病人疾病无进展生存时间可达15个月,效果良好。
Advanced intrahepatic cholangiocarcinoma(ICC)is one of the most common hepatic malignant tumors besides hepatocellular carcinoma,with occult onset,limited treatment and poor prognosis.Systemic treatment is a recommendable solution for advanced unresectable ICC.The authors reported the clinical experience of an ICC patient who underwent transarterial chemoembolization combined with immunotherapy plus target therapy.
作者
张辉
陈志宇
弓毅
戴海粟
谭斌彬
牟玮
张雷达
Zhang Hui;Chen Zhiyu;Gong Yi;Dai Haisu;Tan Binbin;Mu Wei;Zhang Leida(Department of Hepatobiliary Surgery,the First Affiliated Hospital of Army Medical University,Chongqing 400038,China;Department of Vascular Surgery,the First Affiliated Hospital of Army Medical University,Chongqing 400038,China)
出处
《中华消化外科杂志》
CAS
CSCD
北大核心
2021年第S02期37-40,共4页
Chinese Journal of Digestive Surgery
关键词
胆道肿瘤
免疫靶向治疗
经肝动脉化疗栓塞
联合治疗
临床疗效
Biliary tract neoplasms
Immunotherapy plus target therapy
Transarterial chemoembolization
Combination therapy
Clinical efficacy
